PMLS LESSON 9 PART 6 Flashcards
a biorisk management model where one fails if one of
the three components or legs is overlooked or is not addressed
AMP model
The process can be described as a continuous improvement cycle which can be implemented in the management process in the company
risk assessment
Process of identifying the hazards and evaluating
the risks associated with biological agents and toxins, taking into account the adequacy of any existing controls, and deciding whether or not the risks are acceptable
risk assessment
Describes the relative hazard posed by infectious agents or
toxins in the laboratory
risk groups
used in a biological risk
assessment to determine the appropriate biosafety level
primary condition
what are the WHO risk groups?
1- no/low individual and community risk
2- moderate individual risk/ low community risk
3 - high individual risk/ low community risk
4 - both high individual and community risk
microorganisms unlikely to cause human or animal disease
1
Laboratory exposures may cause serious infections, but effective treatment and preventive measures are available, and the risk of spreading infection is very limited
2
The pathogen can cause
human or animal disease, but it is unlikely to be a serious hazard to laboratory workers, community, livestock, etc.
2
Effective treatment and preventive measures are available still
3
Describes a pathogen that usually causes serious disease but doesn’t spread from one infected individual to another, so it’s not as contagious
3
Categorizes a pathogen that usually causes serious disease and can be readily transmitted from one individual to another,
4
Effective treatment and preventive measures are not usually available
4
HIGH individual and community risk
4
low/no community risk and invidual risk
1
